Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands

Treatment options for ADHD in the Netherlands have increased with the introduction of the extended-release formulations of methylphenidate (MPH ER, Concerta(®)) in 2003 and atomoxetine (ATX, Strattera(®)) in 2005, but data on the effect on drug usage patterns are scarce. The objective of the present...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: van den Ban, Els, Souverein, Patrick C., Swaab, Hanna, van Engeland, Herman, Egberts, Toine C. G., Heerdink, Eibert R.
Formato: Artigo
Idioma:Inglês
Publicado: Springer Vienna 2010
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3000908/
https://ncbi.nlm.nih.gov/pubmed/21258431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12402-010-0044-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares